INSIGHTS ON DRUG DEVELOPMENT
-
5 Trends Impacting CMOs In 2025
In 2025, CMOs will navigate Annex 1 compliance, the BioSecure Act’s uncertainty, AI-driven drug development, supply chain challenges from tariffs, and pandemic preparedness strategies.
-
Lessons In Building Connected Lab Operations Across Development And GMP
Building connected operations across development and GMP environments removes bottlenecks and ensures data integrity. Explore practical insights to scale and standardize your lab workflows.
-
Advancing Multiomics Through Intelligent Automation
Modern automation tackles hidden pipetting errors and boosts reproducibility. Discover how your lab can scale confidently, reduce rework, and accelerate multiomic workflows with built-in traceability.
-
Advancing Cell Culture Strategies To Accelerate Biologics Development
Integrated stable expression strategies accelerate biologics material generation, improving scalability, consistency, and early developability insights while reducing bottlenecks, variability, and risks in transitioning from discovery to manufacturing.
-
Redefining OSD Development Through Foresight And Innovation2/12/2026
From early formulation challenges to scale-up and commercial readiness, proactive planning and integrated capabilities help teams anticipate risks, accelerate decision-making, and maintain momentum across development.
-
Solid Formulation: Spray Drying Process7/24/2025
Transform your pharmaceutical development with an innovative spray drying technology that enhances API solubility to improve drug bioavailability and formulation performance.
-
Why Pharmaceutical Scientists Trust The Discovery Core Rheometer5/1/2026
Drug formulations demand more than single‑point viscosity data. Explore how rheology reveals stability, flow, and structural behavior across suspensions, topicals, and injectables.
-
Collaboration An Untapped Fuel For Driving Biopharma R&D10/20/2025
Biopharma’s future depends on collaboration. Discover how cross-industry partnerships and shared resources can accelerate innovation, overcome talent gaps, and strengthen the global R&D ecosystem.
-
Bora Pharmaceuticals Capabilities Update October 2026: Small Molecule Drug Product11/3/2026
Simplify outsourcing across diverse pipelines with flexible dosage-form capabilities, scalable capacity, and support from clinical development to commercial supply.
DRUG DEVELOPMENT SOLUTIONS
-
See how the Waters line of products can help you achieve quality bioanalytical methods
-
Our team of experts can assess processes for suitable application of continuous flow culminating in the custom development of processes incorporating proof-of-concept to cGMP manufacturing and commercialization.
-
Our custom expression platform directly addresses the primary host limitations in early-to-mid stage assay development:
-
Discover the benefits of partnering with a CDMO that offers expanding capacity and capabilities and a far-reaching operational footprint to support your project.
-
Explore our full range of products, each backed by rigorous quality control and regulatory compliance, to find the right solution for your pharmaceutical needs.